JANSSEN ALZHEIMER IMMUNOTHERAPY

Patent Owner

Compare Create Portfolio
1Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 49195
 
 
 
C07K PEPTIDES 2088
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 786
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 482
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4161
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 298
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2150
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 292
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS137
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1114

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2013/0273,574 OLIGOMERIC A-BETA IN THE DIAGNOSIS, PROGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASEMar 13, 13Oct 17, 13[G01N]
2013/0209,453 USE OF TAU TO MONITOR IMMUNOTHERAPYApr 22, 11Aug 15, 13[A61K]
2013/0084,245 PET MONITORING OF A-BETA-DIRECTED IMMUNOTHERAPYFeb 25, 11Apr 04, 13[A61K]
2013/0058,869 Prevention And Treatment Of Amyloidogenic DiseaseOct 10, 11Mar 07, 13[A61P, A61K]
2012/0282,248 PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHYMar 30, 11Nov 08, 12[A61P, A61K]
2012/0276,116 Prevention and Treatment of Amyloidogenic DiseaseOct 11, 11Nov 01, 12[A61P, A61K]
2012/0207,706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing SameFeb 14, 12Aug 16, 12[A61P, A61K, C07K]
2012/0070,379 IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUSSep 13, 11Mar 22, 12[A61P, G06Q, A61K]
2011/0306,756 Prevention and Treatment of Amyloidogenic DiseaseDec 22, 10Dec 15, 11[C07K]
2011/0287,042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing SameJul 07, 11Nov 24, 11[A61P, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,784,810 Treatment of amyloidogenic diseasesOct 17, 08Jul 22, 14[A61K]
8,642,044 Prevention and treatment of amyloidogenic diseaseAug 20, 07Feb 04, 14[A61K]
8,613,920 Treatment of amyloidogenic diseasesJul 27, 07Dec 24, 13[A61P, A61K]
8,535,673 Prevention and treatment of amyloidogenic diseaseAug 20, 04Sep 17, 13[A61K]
8,440,799 Methods of purifying anti A β antibodiesOct 12, 10May 14, 13[C07K]
8,357,781 Neuroactive fragments of APPJun 01, 07Jan 22, 13[C12P, C07K]
8,318,164 Anti A beta antibody formulationDec 14, 09Nov 27, 12[A61K]
8,227,403 A-β immunogenic peptide carrier conjugates and methods of producing sameDec 17, 04Jul 24, 12[A61K, C07K]
8,128,928 Humanized antibodies that recognize beta amyloid peptideAug 13, 07Mar 06, 12[A61K]
8,034,339 Prevention and treatment of amyloidogenic diseaseAug 20, 04Oct 11, 11[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2012/0282,248 PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHYMar 30, 11Nov 08, 12[A61P, A61K]
2012/0276,116 Prevention and Treatment of Amyloidogenic DiseaseOct 11, 11Nov 01, 12[A61P, A61K]
2011/0306,756 Prevention and Treatment of Amyloidogenic DiseaseDec 22, 10Dec 15, 11[C07K]
2011/0135,660 PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASEMar 23, 10Jun 09, 11[A61P, A61K]
2010/0031,377 Prevention and treatment of synucleinopathic and amyloidogenic diseaseAug 09, 05Feb 04, 10[C12N, A61P, A61K, C07K]
2009/0297,511 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEDec 04, 08Dec 03, 09[C12N, C07H, C12P, A61K, C07K]
2009/0155,256 Immunotherapy Regimes Dependent On APOE StatusOct 17, 08Jun 18, 09[C07H, A61P, A61K, C07K]
2008/0292,625 PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHYApr 18, 08Nov 27, 08[A61P, A61K, C07K]
2008/0279,873 ACTIVE IMMUNIZATION TO GENERATE ANTIBODIES TO SOLUBLE A-BETAFeb 25, 08Nov 13, 08[A61P, A61K]
2008/0281,082 HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDEAug 20, 07Nov 13, 08[C07K]
2008/0227,719 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEAug 20, 07Sep 18, 08[A61P, A61K]
2008/0096,818 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEAug 20, 07Apr 24, 08[A61P, A61K]
2008/0050,367 Humanized antibodies that recognize beta amyloid peptideSep 05, 06Feb 28, 08[C12N, A61P, A61K, C07K]
2008/0014,194 Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseApr 06, 07Jan 17, 08[C12N, A61P, A61K, C07K]
2007/0134,762 Immunogenic peptide carrier conjugates and methods of producing sameDec 17, 04Jun 14, 07[C12P, C12Q]
2006/0280,743 Humanized antibodies that recognize beta amyloid peptideApr 28, 06Dec 14, 06[C12N, C07H, C12P, A61K, C07K]
2006/0257,396 Abeta antibodies for use in improving cognitionDec 15, 05Nov 16, 06[A61K]
2006/0240,486 Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodiesDec 15, 05Oct 26, 06[G01N]
2006/0160,161 Methods for assessing antibodies to neurodegenerative disease-associated antigensOct 26, 05Jul 20, 06[G01N]
2006/0153,772 Contextual fear conditioning for predicting immunotherapeutic efficacyDec 15, 05Jul 13, 06[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.